Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J George

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Highlights in renal cell carcinoma from the American Society of Clinical Oncology Genitourinary Cancers Symposium: commentaryDaniel J George
Urology|September 17, 2002
Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylateDaniel J George
Clinical Advances in Hematology & Oncology : H&O|May 7, 2026
Cabozantinib plus nivolumab as first-line therapy for advanced renal cell carcinoma with bone metastases: a clinical case reportDaniel J George
Clinical Advances in Hematology & Oncology : H&O|July 22, 2020
Highlights in Advanced Prostate Cancer from the 2019 ASCO Genitourinary Cancers Symposium: CommentaryDaniel J George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinomaDaniel J George
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Recent advances in the management of castration-resistant prostate cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|July 21, 2023
Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: genitourinary cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
Highlights in advanced prostate cancer from the 2014 American Society of Clinical Oncology genitourinary cancers symposium: commentaryDaniel J George
Clinical Advances in Hematology & Oncology : H&O|August 27, 2019
Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapyDaniel J George
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Highlights in renal cell carcinoma from the American Society of Clinical Oncology Genitourinary Cancers Symposium: commentaryDaniel J George
Urology|September 17, 2002
Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylateDaniel J George
Clinical Advances in Hematology & Oncology : H&O|May 7, 2026
Cabozantinib plus nivolumab as first-line therapy for advanced renal cell carcinoma with bone metastases: a clinical case reportDaniel J George
Clinical Advances in Hematology & Oncology : H&O|July 22, 2020
Highlights in Advanced Prostate Cancer from the 2019 ASCO Genitourinary Cancers Symposium: CommentaryDaniel J George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinomaDaniel J George
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Recent advances in the management of castration-resistant prostate cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|July 21, 2023
Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: genitourinary cancerDaniel J George
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
Highlights in advanced prostate cancer from the 2014 American Society of Clinical Oncology genitourinary cancers symposium: commentaryDaniel J George
Clinical Advances in Hematology & Oncology : H&O|August 27, 2019
Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapyDaniel J George
Pageof 32